Insulin Pump Usage Significantly Reduces CVD Mortality RisksWednesday, August 12, 2015
"We carefully analyzed the findings to eliminate the risk of bias or confounding and concluded that the effect had been fully verified," says lead author and researcher Isabelle Steineck, MD.
Interestingly enough, approximately 20% of Swedish type 1 diabetes patients overall have access to insulin pump therapy. However, earlier studies have shown greater variability which ranges from 12% to almost 30% of patients may receive pumps.
With promising results, it does raise the question about why aren't more people who are eligible for pump therapy and could benefit from reduce CVD risks currently taking advantage of these devices?
"This is good news for anyone with type 1 diabetes," says Soffia Gudbjörnsdottir, diabetologist and director of the Swedish National Diabetes Register. "But not everybody wants to use a pump, and the biggest priority is still to optimize blood glucose monitoring."
Source: University of Gothenberg